专利检索 ap:("Schering Corporation") AND inv:"CELLY, Chander, S." 第 1 页

1.

发明公开
1-[[1-[(2-AMIN0-6-METHYL-4-PYRIDINYL)METHYL]-4-FLU0R0-4-PIPERIDINYL,]CARBONYL]-4-[2-(2-PYRIDINYL)-3H-IMIDAZ0[4, 5-B]PYRIDIN-3-YL]PIPERIDINE USEFUL AS HISTAMINE H3 ANTAGONIST 审中-公开
标题翻译： ALS HISTAMIN-H3-ANTAGONIST GEEIGNETES 1 - [[1 - [（2-氨基-6-甲基-4-吡啶基）甲基] -4-氟-4-哌啶基]羰基] -4- [2-（2-吡啶基））-3H-咪唑并[4,5-b]吡啶-3-基]哌啶

公开(公告)号：EP1931665A1

公开(公告)日：2008-06-18

申请号：EP06803837.1

申请日：2006-09-19

申请人： Schering Corporation

发明人： DE LERA RUIZ, Manuel , ASLANIAN, Robert, G. , BERLIN, Michael, Y. , MCCORMICK, Kevin, D. , CELLY, Chander, S.

IPC分类号： C07D471/04 , A61K31/437 , A61P37/08 , A61P3/00

CPC分类号： C07D471/04

摘要： The present invention discloses the compound of Formula I and pharmaceutically acceptable salts and solvates thereof. The invention also relates to pharmaceutical compositions comprising the Compound of Formula I and its use in treating obesity, metabolic syndrome, diabetes, hepatic lipidosis or nonalcoholic fatty liver disease. The invention also relates to the use of a combination of the Compound of Formula I with additional therapeutic agents for treating obesity, metabolic syndrome, diabetes, hepatic lipidosis or nonalcoholic fatty liver disease.